These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22145013)

  • 1. Drug discovery toward antagonists of methyl-lysine binding proteins.
    Herold JM; Ingerman LA; Gao C; Frye SV
    Curr Chem Genomics; 2011; 5():51-61. PubMed ID: 22145013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical tools targeting readers of lysine methylation.
    Ortiz G; Kutateladze TG; Fujimori DG
    Curr Opin Chem Biol; 2023 Jun; 74():102286. PubMed ID: 36948085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting non-bromodomain chromatin readers.
    Arrowsmith CH; Schapira M
    Nat Struct Mol Biol; 2019 Oct; 26(10):863-869. PubMed ID: 31582844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A General TR-FRET Assay Platform for High-Throughput Screening and Characterizing Inhibitors of Methyl-Lysine Reader Proteins.
    Rectenwald JM; Hardy PB; Norris-Drouin JL; Cholensky SH; James LI; Frye SV; Pearce KH
    SLAS Discov; 2019 Jul; 24(6):693-700. PubMed ID: 31017815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyllysine binding domains: Structural insight and small molecule probe development.
    Teske KA; Hadden MK
    Eur J Med Chem; 2017 Aug; 136():14-35. PubMed ID: 28478342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved methods for targeting epigenetic reader domains of acetylated and methylated lysine.
    Engelberg IA; Foley CA; James LI; Frye SV
    Curr Opin Chem Biol; 2021 Aug; 63():132-144. PubMed ID: 33852996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library.
    Shell DJ; Rectenwald JM; Buttery PH; Johnson RL; Foley CA; Guduru SKR; Uguen M; Rubiano JS; Zhang X; Li F; Norris-Drouin JL; Axtman M; Brian Hardy P; Vedadi M; Frye SV; James LI; Pearce KH
    SLAS Discov; 2022 Dec; 27(8):428-439. PubMed ID: 36272689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of epigenetic reader domains.
    Greschik H; Schüle R; Günther T
    Expert Opin Drug Discov; 2017 May; 12(5):449-463. PubMed ID: 28277835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards understanding methyllysine readout.
    Musselman CA; Khorasanizadeh S; Kutateladze TG
    Biochim Biophys Acta; 2014 Aug; 1839(8):686-93. PubMed ID: 24727128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical inhibitors targeting histone methylation readers.
    Huang X; Chen Y; Xiao Q; Shang X; Liu Y
    Pharmacol Ther; 2024 Apr; 256():108614. PubMed ID: 38401773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodomain Histone Readers and Cancer.
    Jain AK; Barton MC
    J Mol Biol; 2017 Jun; 429(13):2003-2010. PubMed ID: 27890782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Construction of a Focused DNA-Encoded Library for Multivalent Chromatin Reader Proteins.
    Rectenwald JM; Guduru SKR; Dang Z; Collins LB; Liao YE; Norris-Drouin JL; Cholensky SH; Kaufmann KW; Hammond SM; Kireev DB; Frye SV; Pearce KH
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32098353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic targets and drug discovery: part 1: histone methylation.
    Liu Y; Liu K; Qin S; Xu C; Min J
    Pharmacol Ther; 2014 Sep; 143(3):275-94. PubMed ID: 24704322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated methyl readers: Functional communications in cancer.
    Park IG; Jeon M; Kim H; Lee JM
    Semin Cancer Biol; 2022 Aug; 83():88-99. PubMed ID: 33753223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine/lysine-methyl/methyl switches: biochemical role of histone arginine methylation in transcriptional regulation.
    Migliori V; Phalke S; Bezzi M; Guccione E
    Epigenomics; 2010 Feb; 2(1):119-37. PubMed ID: 22122749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins.
    Wigle TJ; Herold JM; Senisterra GA; Vedadi M; Kireev DB; Arrowsmith CH; Frye SV; Janzen WP
    J Biomol Screen; 2010 Jan; 15(1):62-71. PubMed ID: 20008125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond histone methyl-lysine binding: how malignant brain tumor (MBT) protein L3MBTL1 impacts chromatin structure.
    Trojer P; Reinberg D
    Cell Cycle; 2008 Mar; 7(5):578-85. PubMed ID: 18256536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting epigenetic reader domains by chemical biology.
    Cipriano A; Sbardella G; Ciulli A
    Curr Opin Chem Biol; 2020 Aug; 57():82-94. PubMed ID: 32739717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Peptidomimetic Ligand Targeting the Chromodomain of MPP8 Reveals HRP2's Association with the HUSH Complex.
    Waybright JM; Clinkscales SE; Barnash KD; Budziszewski GR; Rectenwald JM; Chiarella AM; Norris-Drouin JL; Cholensky SH; Pearce KH; Herring LE; McGinty RK; Hathaway NA; James LI
    ACS Chem Biol; 2021 Sep; 16(9):1721-1736. PubMed ID: 34415726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion.
    Appikonda S; Thakkar KN; Shah PK; Dent SYR; Andersen JN; Barton MC
    J Biol Chem; 2018 May; 293(19):7476-7485. PubMed ID: 29523690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.